Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
NCT01905774
·
clinicaltrials.gov ↗
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Thalassemia
Iron Overload
Interventions
DRUG:
Deferasirox
Sponsor
HaEmek Medical Center, Israel